Role of RAPID score and surgery in the management of pleural infection: a single center retrospective study.

Pleural infection Renal (urea level), Age, Pleural fluid purulence, source of Infection and Denutrition (albumin level) score (RAPID score) empyema thoracic surgery

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
31 Oct 2023
Historique:
received: 09 11 2022
accepted: 31 03 2023
medline: 16 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: ppublish

Résumé

The RAPID [Renal (urea level), Age, Pleural fluid purulence, source of Infection and Denutrition (albumin level)] score classifies patients with pleural infection according to mortality risk at 3 months. This study aims to assess the applicability of this score in a thoracic surgery department and to determine the impact of surgery in the management of pleural infection depending on the Rapid score. In this single center retrospective study, patients managed for pleural infection, from January 1st 2013 to June 30th 2019, were included. The primary endpoint was the probability of survival at 6 months and 12 months depending on the RAPID score. Secondary endpoint was the probability of survival at 6 and 12 months in patients who had surgeries (surgical treatment group) and patients who didn't have surgery (medical treatment group). Seventy-four patients were included, with a median age of 54.5 years. According to the RAPID score, the low-, medium- and high-risk groups had 30, 30 and 14 patients respectively. The probability of survival at 6 and 12 months in the low- and medium-risk groups were both 0.967 [95% confidence index (CI95): 0.905-1] whereas, the probabilities of survival at 6 and 12 months in the high-risk group was significantly lower at 0.571 (CI95: 0.363-0.899) and 0.357 (CI95: 0.177-0.721) respectively (P<0.0001). The probabilities of survival at 6 months and 12 months in the medical treatment group was 0.875 (CI95: 0.786-0.974) and 0.812 (CI95: 0.704-0.931) respectively compared to the surgical treatment group where probabilities of survival at 6 and 12 months were both 0.923 (CI95: 0.826-1) (P=0.26). In our study, patients with pleural infection, classified as high-risk according to the RAPID score, had a lower survival rate compared to low- and medium-risk patients. No difference in survival rate was found between patients classified as low- and medium-risk. In selected patients, surgical management seems to decrease mortality compared to exclusive medical management: this result should be confirmed in larger prospective studies.

Sections du résumé

Background UNASSIGNED
The RAPID [Renal (urea level), Age, Pleural fluid purulence, source of Infection and Denutrition (albumin level)] score classifies patients with pleural infection according to mortality risk at 3 months. This study aims to assess the applicability of this score in a thoracic surgery department and to determine the impact of surgery in the management of pleural infection depending on the Rapid score.
Methods UNASSIGNED
In this single center retrospective study, patients managed for pleural infection, from January 1st 2013 to June 30th 2019, were included. The primary endpoint was the probability of survival at 6 months and 12 months depending on the RAPID score. Secondary endpoint was the probability of survival at 6 and 12 months in patients who had surgeries (surgical treatment group) and patients who didn't have surgery (medical treatment group).
Results UNASSIGNED
Seventy-four patients were included, with a median age of 54.5 years. According to the RAPID score, the low-, medium- and high-risk groups had 30, 30 and 14 patients respectively. The probability of survival at 6 and 12 months in the low- and medium-risk groups were both 0.967 [95% confidence index (CI95): 0.905-1] whereas, the probabilities of survival at 6 and 12 months in the high-risk group was significantly lower at 0.571 (CI95: 0.363-0.899) and 0.357 (CI95: 0.177-0.721) respectively (P<0.0001). The probabilities of survival at 6 months and 12 months in the medical treatment group was 0.875 (CI95: 0.786-0.974) and 0.812 (CI95: 0.704-0.931) respectively compared to the surgical treatment group where probabilities of survival at 6 and 12 months were both 0.923 (CI95: 0.826-1) (P=0.26).
Conclusions UNASSIGNED
In our study, patients with pleural infection, classified as high-risk according to the RAPID score, had a lower survival rate compared to low- and medium-risk patients. No difference in survival rate was found between patients classified as low- and medium-risk. In selected patients, surgical management seems to decrease mortality compared to exclusive medical management: this result should be confirmed in larger prospective studies.

Identifiants

pubmed: 37969265
doi: 10.21037/jtd-22-1599
pii: jtd-15-10-5340
pmc: PMC10636464
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5340-5348

Informations de copyright

2023 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-1599/coif). The authors have no conflicts of interest to declare.

Références

Lancet Oncol. 2016 Jun;17(6):836-844
pubmed: 27160473
Langenbecks Arch Surg. 2017 Feb;402(1):15-26
pubmed: 27815709
Thorax. 2011 Aug;66(8):663-8
pubmed: 21617169
N Engl J Med. 2005 Mar 3;352(9):865-74
pubmed: 15745977
Curr Opin Pulm Med. 2013 Jul;19(4):350-6
pubmed: 23508113
Chest. 2000 Oct;118(4):1158-71
pubmed: 11035692
Can Respir J. 2008 Mar;15(2):85-9
pubmed: 18354748
Am J Med Sci. 2003 Jul;326(1):9-14
pubmed: 12861120
Thorax. 2010 Aug;65 Suppl 2:ii41-53
pubmed: 20696693
Eur J Cardiothorac Surg. 2015 Nov;48(5):642-53
pubmed: 26254467
Clin Sci (Lond). 2003 Nov;105(5):601-7
pubmed: 12826021
Eur Respir J. 2020 Nov 26;56(5):
pubmed: 32675200
ANZ J Surg. 2006 Mar;76(3):120-2
pubmed: 16626345
Thorax. 2021 Nov;76(11):1117-1123
pubmed: 33785584
Chest. 2014 Apr;145(4):848-855
pubmed: 24264558
N Engl J Med. 2011 Aug 11;365(6):518-26
pubmed: 21830966
J Thorac Cardiovasc Surg. 2007 Feb;133(2):346-51
pubmed: 17258562
Eur Respir J. 1997 Oct;10(10):2411-8
pubmed: 9387973
Lung. 2018 Oct;196(5):623-629
pubmed: 30099584
Respirology. 2011 May;16(4):598-603
pubmed: 21382129
J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-e146
pubmed: 28274565
Eur Respir Rev. 2010 Sep;19(117):220-8
pubmed: 20956197

Auteurs

Laura Simon (L)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Yaniss Belaroussi (Y)

Department of Thoracic Surgery, Haut-Leveque Hospital Bordeaux University, University of Bordeaux, Bordeaux, France.

Anna Vayssette (A)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Theresa Khalife (T)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Marielle Le Roux (M)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Denis Debrosse (D)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Mihaela Giol (M)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Jalal Assouad (J)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Harry Etienne (H)

Department of Thoracic and Vascular Surgery, Tenon University Hospital, Sorbonne University, Paris, France.

Classifications MeSH